
Thurman Michael Wheeler
Examiner (ID: 17510, Phone: (571)270-1307 , Office: P/1619 )
| Most Active Art Unit | 1619 |
| Art Unit(s) | 1619 |
| Total Applications | 728 |
| Issued Applications | 283 |
| Pending Applications | 72 |
| Abandoned Applications | 384 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18077332
[patent_doc_number] => 20220402944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => Functionalized Mesoporous Silica via an Aminosilane Surfactant Ion Exchange Reaction: Controlled Scaffold Design and Nitric Oxide Release
[patent_app_type] => utility
[patent_app_number] => 17/821371
[patent_app_country] => US
[patent_app_date] => 2022-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8868
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17821371
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/821371 | Functionalized Mesoporous Silica via an Aminosilane Surfactant Ion Exchange Reaction: Controlled Scaffold Design and Nitric Oxide Release | Aug 21, 2022 | Pending |
Array
(
[id] => 19681686
[patent_doc_number] => 20250000231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-02
[patent_title] => ARTIFICIAL NAIL FOR USE IN THE TREATMENT OF A NAIL DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/292174
[patent_app_country] => US
[patent_app_date] => 2022-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7433
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18292174
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/292174 | ARTIFICIAL NAIL FOR USE IN THE TREATMENT OF A NAIL DISEASE | Aug 3, 2022 | Pending |
Array
(
[id] => 18295477
[patent_doc_number] => 20230105163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => ORAL TESTOSTERONE ESTER FORMULATIONS AND METHODS OF TREATING TESTOSTERONE DEFICIENCY COMPRISING SAME
[patent_app_type] => utility
[patent_app_number] => 17/814296
[patent_app_country] => US
[patent_app_date] => 2022-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11073
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17814296
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/814296 | ORAL TESTOSTERONE ESTER FORMULATIONS AND METHODS OF TREATING TESTOSTERONE DEFICIENCY COMPRISING SAME | Jul 21, 2022 | Pending |
Array
(
[id] => 18075733
[patent_doc_number] => 20220401345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => POLYMER-BASED ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/869477
[patent_app_country] => US
[patent_app_date] => 2022-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24534
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17869477
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/869477 | POLYMER-BASED ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREOF | Jul 19, 2022 | Pending |
Array
(
[id] => 20452969
[patent_doc_number] => 12516019
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-06
[patent_title] => Amphoteric compounds
[patent_app_type] => utility
[patent_app_number] => 17/864827
[patent_app_country] => US
[patent_app_date] => 2022-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8779
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17864827
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/864827 | Amphoteric compounds | Jul 13, 2022 | Issued |
Array
(
[id] => 18258452
[patent_doc_number] => 20230085492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => SHEAR-THINNING COMPOSITIONS AS AN INTRAVASCULAR EMBOLIC AGENT
[patent_app_type] => utility
[patent_app_number] => 17/862959
[patent_app_country] => US
[patent_app_date] => 2022-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20171
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17862959
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/862959 | SHEAR-THINNING COMPOSITIONS AS AN INTRAVASCULAR EMBOLIC AGENT | Jul 11, 2022 | Pending |
Array
(
[id] => 18107935
[patent_doc_number] => 20230000815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => Acid-Labile Chemotherapeutic Compounds and Compositions
[patent_app_type] => utility
[patent_app_number] => 17/840455
[patent_app_country] => US
[patent_app_date] => 2022-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13451
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17840455
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/840455 | Acid-Labile Chemotherapeutic Compounds and Compositions | Jun 13, 2022 | Abandoned |
Array
(
[id] => 19379470
[patent_doc_number] => 20240269340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => MICROSPHERES WITH FLOW THROUGH VOIDS AS EMBOLIC AND DRUG DELIVERY AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/569332
[patent_app_country] => US
[patent_app_date] => 2022-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13040
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18569332
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/569332 | MICROSPHERES WITH FLOW THROUGH VOIDS AS EMBOLIC AND DRUG DELIVERY AGENTS | Jun 11, 2022 | Pending |
Array
(
[id] => 18239914
[patent_doc_number] => 20230072225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => CONTROLLED RELEASE COMPOSITION AND METHOD
[patent_app_type] => utility
[patent_app_number] => 17/836314
[patent_app_country] => US
[patent_app_date] => 2022-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4521
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17836314
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/836314 | CONTROLLED RELEASE COMPOSITION AND METHOD | Jun 8, 2022 | Abandoned |
Array
(
[id] => 17881386
[patent_doc_number] => 20220296863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => DRUG RELEASING COATINGS FOR MEDICAL DEVICES
[patent_app_type] => utility
[patent_app_number] => 17/829554
[patent_app_country] => US
[patent_app_date] => 2022-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11095
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17829554
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/829554 | DRUG RELEASING COATINGS FOR MEDICAL DEVICES | May 31, 2022 | Pending |
Array
(
[id] => 19316943
[patent_doc_number] => 20240238483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => SYSTEM FOR SELECTIVE THERMAL INHIBITION OF THE ACTIVITY OF NERVES AND NEURONAL STRUCTURES
[patent_app_type] => utility
[patent_app_number] => 18/561463
[patent_app_country] => US
[patent_app_date] => 2022-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4956
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18561463
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/561463 | SYSTEM FOR SELECTIVE THERMAL INHIBITION OF THE ACTIVITY OF NERVES AND NEURONAL STRUCTURES | May 12, 2022 | Pending |
Array
(
[id] => 18222432
[patent_doc_number] => 20230061426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => ANTIOXIDANT POLYMERIC BIOMATERIAL FOR TISSUE ENGINEERING AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/736256
[patent_app_country] => US
[patent_app_date] => 2022-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10535
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17736256
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/736256 | ANTIOXIDANT POLYMERIC BIOMATERIAL FOR TISSUE ENGINEERING AND METHODS OF USING SAME | May 3, 2022 | Pending |
Array
(
[id] => 17790304
[patent_doc_number] => 20220249395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => PHARMACEUTICAL FORMULATIONS FOR A LIQUID DOSAGE FORM AND A CONTROLLED RELEASE DOSAGE FORM
[patent_app_type] => utility
[patent_app_number] => 17/727301
[patent_app_country] => US
[patent_app_date] => 2022-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12400
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17727301
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/727301 | PHARMACEUTICAL FORMULATIONS FOR A LIQUID DOSAGE FORM AND A CONTROLLED RELEASE DOSAGE FORM | Apr 21, 2022 | Abandoned |
Array
(
[id] => 17774820
[patent_doc_number] => 20220241169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => USE OF DIHYDROISOQUINOLINIUM SALTS FOR TREATING KERATIN MATERIALS, COMPOSITIONS AND IMPLEMENTATION PROCESSES
[patent_app_type] => utility
[patent_app_number] => 17/718479
[patent_app_country] => US
[patent_app_date] => 2022-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7118
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17718479
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/718479 | USE OF DIHYDROISOQUINOLINIUM SALTS FOR TREATING KERATIN MATERIALS, COMPOSITIONS AND IMPLEMENTATION PROCESSES | Apr 11, 2022 | Abandoned |
Array
(
[id] => 17928510
[patent_doc_number] => 20220323635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => FABRIC COMPOSITIONS COMPRISING ATTACHED ASCORBIC ACID
[patent_app_type] => utility
[patent_app_number] => 17/713871
[patent_app_country] => US
[patent_app_date] => 2022-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12965
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17713871
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/713871 | FABRIC COMPOSITIONS COMPRISING ATTACHED ASCORBIC ACID | Apr 4, 2022 | Abandoned |
Array
(
[id] => 17928232
[patent_doc_number] => 20220323357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF IMMUNE CHECKPOINT RESISTANT CANCERS
[patent_app_type] => utility
[patent_app_number] => 17/714010
[patent_app_country] => US
[patent_app_date] => 2022-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29837
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17714010
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/714010 | COMPOSITIONS AND METHODS FOR TREATMENT OF IMMUNE CHECKPOINT RESISTANT CANCERS | Apr 4, 2022 | Abandoned |
Array
(
[id] => 17748034
[patent_doc_number] => 20220226237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => Nutritional Compositions For The Management of Hyponatremia
[patent_app_type] => utility
[patent_app_number] => 17/713134
[patent_app_country] => US
[patent_app_date] => 2022-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1947
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17713134
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/713134 | Nutritional compositions for the management of hyponatremia | Apr 3, 2022 | Issued |
Array
(
[id] => 19744115
[patent_doc_number] => 20250032680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-30
[patent_title] => ANTIVIRAL AND ANTIMICROBIAL COATINGS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/551105
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23519
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 222
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18551105
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/551105 | ANTIVIRAL AND ANTIMICROBIAL COATINGS AND METHODS THEREOF | Mar 20, 2022 | Pending |
Array
(
[id] => 17655207
[patent_doc_number] => 20220175672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => COMPOSITIONS AND METHODS FOR SUSTAINED DRUG RELEASE FROM AN INJECTABLE HYDROGEL
[patent_app_type] => utility
[patent_app_number] => 17/677295
[patent_app_country] => US
[patent_app_date] => 2022-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32278
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17677295
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/677295 | COMPOSITIONS AND METHODS FOR SUSTAINED DRUG RELEASE FROM AN INJECTABLE HYDROGEL | Feb 21, 2022 | Pending |
Array
(
[id] => 17790296
[patent_doc_number] => 20220249387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => POLYMER PROTEIN MICROPARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/677282
[patent_app_country] => US
[patent_app_date] => 2022-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10441
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17677282
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/677282 | Polymer protein microparticles | Feb 21, 2022 | Issued |